Tg Therapeutics TGTX
NASDAQ TGTX
$55.99 -0.72 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012)

Tg Therapeutics (TGTX) posted quarterly Preferred Shares of $1109.0 for Q1 2012, up 168.52% quarter-over-quarter from $413.0 in Q4 2011.

Analysis

Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012) Analysis & Trends

Tg Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $1109.0 for Q1 2012.

  • In Q1 2012, Preferred Shares changed N/A year-over-year to $1109.0; the TTM figure through Mar 2012 stood at $1109.0 (changed N/A YoY), while the FY2012 annual figure was $1109.0, changed N/A from the prior year.
  • Preferred Shares for Q1 2012 stood at $1109.0, up from $413.0 in the prior quarter.
  • The five-year high for Preferred Shares was $1109.0 in Q1 2012, with the low at $413.0 in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Tg Therapeutics 7.97 Bn 7.29 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 1,109.00
Dec 31, 2011 413.00